The trademark application DIRECTLINE was filed by ReBalance Health, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on March 25, 2024, and it was registered by office on July 2, 2024 without any oppositions.
The application was filed in Danish (English was selected as the second language).